COST-EFFECTIVENESS OF THE CELL-BASED QUADRIVALENT VERSUS THE STANDARD EGG-BASED QUADRIVALENT INFLUENZA VACCINE IN GERMANY.

被引：0
|
作者：
Cai, R. [1 ]
Eichner, M. [2 ]
Schwehm, M. [3 ]
Rajaram, S. [4 ]
Joaquin, F. M. Q. [5 ]
Lamotte, M. [6 ]
机构：
[1] IQVIA, Amsterdam, Netherlands
[2] Univ Tubingen, Tubingen, Germany
[3] ExploSYS GmbH, Leinfelden Echterdingen, Germany
[4] Seqirus, Maidenhead, Berks, England
[5] Seqirus, Summit, NJ USA
[6] IQVIA, Zaventem, Belgium
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN32
引用
收藏
页码：S548 / S548
页数：1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [12] Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza Season
    Imran, Mahrukh
    Ortiz, Justin R.
    McLean, Huong Q.
    Fisher, Lauren
    O'Brien, Dan
    Bonafede, Machaon
    Mansi, James A.
    Boikos, Constantina
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (09) : 769 - 774
  • [13] A SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE
    van Maanen, B. M.
    Postma, M. J.
    de Boer, P. T.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [14] COST-EFFECTIVENESS ANALYSIS OF QUADRIVALENT INFLUENZA VACCINE IN SPAIN
    Garcia Rojas, A.
    Ortiz de Lejarazu, R. L.
    Reina, J.
    Callejo, D.
    Cuervo Uria, J.
    Morano Larragueta, R.
    VALUE IN HEALTH, 2015, 18 (07) : A588 - A588
  • [15] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [16] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [17] RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A US OBSERVATIONAL COHORT STUDY
    Pelton, S.
    Postma, M.
    Divino, V
    Mould-Quevedo, J. F.
    DeKoven, M.
    Krishnarajah, G.
    VALUE IN HEALTH, 2020, 23 : S168 - S168
  • [18] Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
    Rumi, Filippo
    Basile, Michele
    Cicchetti, Americo
    Alvarez, Fabian P.
    Azzi, Maria Vittoria
    Muzii, Barbara
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [19] Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
    Jiang, Minghuan
    Li, Pengchao
    Wang, Weihua
    Zhao, Mingyue
    Atif, Naveel
    Zhu, Shan
    Fang, Yu
    VACCINE, 2020, 38 (05) : 1057 - 1064
  • [20] Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
    Nham, Eliel
    Seong, Hye
    Hyun, Hakjun
    Yoon, Jin Gu
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, Eugene
    Choi, Leejung
    Lee, Jung-Min
    Song, Joon Young
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
12345